Trevi Therapeutics, Inc.TRVINASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+104.5%
5Y CAGR+44.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+104.5%/yr
vs -27.0%/yr prior
5Y CAGR
+44.0%/yr
Recent acceleration
Acceleration
+131.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.2x
Strong expansion
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.91 | +137.3% |
| 2024 | 4.18 | +159.9% |
| 2023 | 1.61 | +38.7% |
| 2022 | 1.16 | +10.8% |
| 2021 | 1.05 | -34.7% |
| 2020 | 1.60 | +30.6% |
| 2019 | 1.23 | -70.0% |
| 2018 | 4.09 | -14.6% |
| 2017 | 4.79 | +165.4% |
| 2016 | -7.31 | - |